CONATUS PHARMACEUTICALS INC - COM (CNAT)

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
5,880,187
Share change
-998
Total reported value
$37,905,677
Price per share
$6.45
Number of holders
36
Value change
-$6,132
Number of sells
1

Institutional Holders of CONATUS PHARMACEUTICALS INC - COM (CNAT) as of Q4 2013

As of 31 Dec 2013, CONATUS PHARMACEUTICALS INC - COM (CNAT) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,880,187 shares. The largest 10 holders included MPM ASSET MANAGEMENT LLC, Polar Capital LLP, JENNISON ASSOCIATES LLC, ADAGE CAPITAL PARTNERS GP LLC, JANUS CAPITAL MANAGEMENT LLC, BlackRock Advisors LLC, PUTNAM INVESTMENTS LLC, BlackRock Fund Advisors, Weiss Multi-Strategy Advisers LLC, and DAFNA Capital Management LLC. This page lists 36 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.